STAR Protocols (Mar 2023)

Inducing primary brainstem gliomas in genetically engineered mice using RCAS/TVA retroviruses and Cre/loxP recombination

  • Loren B. Weidenhammer,
  • Harrison Q. Liu,
  • Lixia Luo,
  • Nerissa T. Williams,
  • Katherine Deland,
  • David G. Kirsch,
  • Zachary J. Reitman

Journal volume & issue
Vol. 4, no. 1
p. 102094

Abstract

Read online

Summary: Genetically engineered mice are commonly used to model brainstem gliomas in pre-clinical research. One technique for inducing primary tumors in these genetically engineered mice involves delivering viral vectors containing the code for gene-editing proteins. We present a protocol for generating primary brainstem gliomas using the RCAS-TVA retroviral delivery system and the Cre/loxP gene editing system. We describe steps for transfecting and harvesting chicken fibroblast cells, intracranially injecting cells into mice, imaging primary tumors, and treating primary tumors with focal, image-guided brain irradiation.For complete details on the use and execution of this protocol, please refer to Deland et al. (2021).1 : Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics.

Keywords